These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24782291)

  • 21. Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial.
    Agarwal N; Rice SP; Bolusani H; Luzio SD; Dunseath G; Ludgate M; Rees DA
    J Clin Endocrinol Metab; 2010 Feb; 95(2):722-30. PubMed ID: 19996308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
    Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X
    Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptor gamma agonism modifies the effects of growth hormone on lipolysis and insulin sensitivity.
    Krag MB; Nielsen S; Guo Z; Pedersen SB; Schmitz O; Christiansen JS; Jørgensen JO
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):452-61. PubMed ID: 18331610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study.
    Ruilope L; Hanefeld M; Lincoff AM; Viberti G; Meyer-Reigner S; Mudie N; Wieczorek Kirk D; Malmberg K; Herz M
    BMC Nephrol; 2014 Nov; 15():180. PubMed ID: 25407798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pioglitazone increases adiponectin levels in nondiabetic patients with coronary artery disease.
    Patel SR; Mailloux LM; Coppola JT; Mindrescu C; Staniloae CS
    Coron Artery Dis; 2008 Aug; 19(5):349-53. PubMed ID: 18580598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pioglitazone-induced insulin sensitization improves vascular endothelial function in nondiabetic patients with essential hypertension.
    Horio T; Suzuki M; Takamisawa I; Suzuki K; Hiuge A; Yoshimasa Y; Kawano Y
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1626-30. PubMed ID: 16364837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tetrahydrobiopterin Supplementation Improves Endothelial Function But Does Not Alter Aortic Stiffness in Patients With Rheumatoid Arthritis.
    Mäki-Petäjä KM; Day L; Cheriyan J; Hall FC; Östör AJ; Shenker N; Wilkinson IB
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26896473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression.
    Kemp DE; Schinagle M; Gao K; Conroy C; Ganocy SJ; Ismail-Beigi F; Calabrese JR
    CNS Drugs; 2014 Jun; 28(6):571-81. PubMed ID: 24715548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves cardiometabolic risk and renal inflammation in murine lupus.
    Zhao W; Thacker SG; Hodgin JB; Zhang H; Wang JH; Park JL; Randolph A; Somers EC; Pennathur S; Kretzler M; Brosius FC; Kaplan MJ
    J Immunol; 2009 Aug; 183(4):2729-40. PubMed ID: 19620300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pioglitazone improves myocardial blood flow and glucose utilization in nondiabetic patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled study.
    Naoumova RP; Kindler H; Leccisotti L; Mongillo M; Khan MT; Neuwirth C; Seed M; Holvoet P; Betteridge J; Camici PG
    J Am Coll Cardiol; 2007 Nov; 50(21):2051-8. PubMed ID: 18021872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor agonist (pioglitazone) with exogenous adiponectin ameliorates arterial stiffness and oxidative stress in diabetic Wistar Kyoto rats.
    Afzal S; Sattar MA; Johns EJ; Eseyin OA
    Eur J Pharmacol; 2021 Sep; 907():174218. PubMed ID: 34111396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity.
    Yarasheski KE; Cade WT; Overton ET; Mondy KE; Hubert S; Laciny E; Bopp C; Lassa-Claxton S; Reeds DN
    Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E243-51. PubMed ID: 20959530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity.
    Rudofsky G; Reismann P; Grafe IA; Konrade I; Djuric Z; Tafel J; Buchbinder S; Zorn M; Humpert PM; Hamann A; Morcos M; Nawroth PP; Bierhaus A
    Horm Metab Res; 2007 Sep; 39(9):665-71. PubMed ID: 17846974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study.
    Tripathy D; Daniele G; Fiorentino TV; Perez-Cadena Z; Chavez-Velasquez A; Kamath S; Fanti P; Jenkinson C; Andreozzi F; Federici M; Gastaldelli A; Defronzo RA; Folli F
    Diabetologia; 2013 Oct; 56(10):2153-63. PubMed ID: 23811853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dual peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin.
    Tonstad S; Retterstøl K; Ose L; Ohman KP; Lindberg MB; Svensson M
    Metabolism; 2007 Sep; 56(9):1285-92. PubMed ID: 17697874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pioglitazone prevents the endothelial dysfunction induced by ischemia and reperfusion in healthy subjects.
    Sakatani Y; Miyoshi T; Oe H; Noda Y; Ohno Y; Nakamura K; Saito Y; Osawa K; Morita H; Kohno K; Ito H
    J Cardiovasc Pharmacol; 2014 Oct; 64(4):326-31. PubMed ID: 24887686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double-blind randomized controlled pilot trial.
    Schmitz JM; Green CE; Hasan KM; Vincent J; Suchting R; Weaver MF; Moeller FG; Narayana PA; Cunningham KA; Dineley KT; Lane SD
    Addiction; 2017 Oct; 112(10):1861-1868. PubMed ID: 28498501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists on glycemic control, lipid profile and cardiovascular risk.
    Derosa G; Maffioli P
    Curr Mol Pharmacol; 2012 Jun; 5(2):272-81. PubMed ID: 22122457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effect of Treatments for Rheumatoid Arthritis on Endothelial Dysfunction Evaluated by Flow-Mediated Vasodilation in Patients with Rheumatoid Arthritis.
    Kotani K; Miyamoto M; Ando H
    Curr Vasc Pharmacol; 2017; 15(1):10-18. PubMed ID: 27739363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of hydroxychloroquine on insulin sensitivity and lipid parameters in rheumatoid arthritis patients without diabetes mellitus: a randomized, blinded crossover trial.
    Solomon DH; Garg R; Lu B; Todd DJ; Mercer E; Norton T; Massarotti E
    Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1246-51. PubMed ID: 24470436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.